The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Fitzgerald Meghan | Director | Option exercise(M) | 70K | $8.80 | $616K |
| Mar 26, 2026 | Fitzgerald Meghan | Director | Sell(S) | 70K | $27.45 | $1.9M |
| Mar 26, 2026 | Fitzgerald Meghan | Director | Option exercise(M) | 70K | — | $0 |
| Mar 20, 2026 | Humes Jennifer | Chief Accounting Officer | Tax withholding(F) | 15K | $27.70 | $402K |
| Mar 20, 2026 | Pulik Richard | CFO | Tax withholding(F) | 2K | $27.70 | $43K |
| Mar 17, 2026 | Venker Eric | President & Immunovant CEO | Sell(S) | 200K | $28.24 | $5.6M |
| Mar 17, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | $3.85 | $770K |
| Mar 17, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | — | $0 |
| Mar 16, 2026 | Epperly Melissa B, | Director | Sell(S) | 42K | $28.68 | $1.2M |
| Feb 23, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 587K | $3.85 | $2.3M |
| Feb 23, 2026 | Torti Frank | President and Vant Chair | Sell(S) | 587K | $27.51 | $16.2M |
| Feb 23, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 587K | — | $0 |
| Feb 20, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 1.0M | $3.85 | $3.9M |
| Feb 20, 2026 | Torti Frank | President and Vant Chair | Sell(S) | 1.0M | $27.15 | $27.5M |
| Feb 20, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 1.0M | — | $0 |
| Feb 20, 2026 | Venker Eric | President & Immunovant CEO | Tax withholding(F) | 7K | $27.15 | $191K |
| Feb 20, 2026 | Pulik Richard | CFO | Tax withholding(F) | 1K | $27.15 | $27K |
| Feb 19, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 1.4M | $3.85 | $5.4M |
| Feb 19, 2026 | Torti Frank | President and Vant Chair | Sell(S) | 1.4M | $27.42 | $38.4M |
| Feb 19, 2026 | Torti Frank | President and Vant Chair | Option exercise(M) | 1.4M | — | $0 |
| Feb 13, 2026 | QVT Financial LP | Insider | Sell(S) | 225K | $26.50 | $6.0M |
| Feb 13, 2026 | QVT Financial LP | Insider | Sell(S) | 151K | $26.49 | $4.0M |
| Feb 13, 2026 | Gold Daniel Allen | Director | Sell(S) | 225K | $26.50 | $6.0M |
| Feb 13, 2026 | Gold Daniel Allen | Director | Sell(S) | 151K | $26.49 | $4.0M |
| Feb 13, 2026 | Manchester Keith S | Director | Sell(S) | 151K | $26.49 | $4.0M |
| Feb 13, 2026 | Manchester Keith S | Director | Sell(S) | 225K | $26.50 | $6.0M |
| Feb 13, 2026 | Venker Eric | President & Immunovant CEO | Sell(S) | 200K | $26.49 | $5.3M |
| Feb 13, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | $3.85 | $770K |
| Feb 13, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | — | $0 |
| Feb 12, 2026 | QVT Financial LP | Insider | Sell(S) | 150K | $26.72 | $4.0M |
| Feb 12, 2026 | QVT Financial LP | Insider | Sell(S) | 275K | $26.76 | $7.4M |
| Feb 12, 2026 | Gold Daniel Allen | Director | Sell(S) | 150K | $26.72 | $4.0M |
| Feb 12, 2026 | Gold Daniel Allen | Director | Sell(S) | 275K | $26.76 | $7.4M |
| Feb 12, 2026 | Manchester Keith S | Director | Sell(S) | 275K | $26.76 | $7.4M |
| Feb 12, 2026 | Manchester Keith S | Director | Sell(S) | 150K | $26.72 | $4.0M |
| Feb 11, 2026 | QVT Financial LP | Insider | Sell(S) | 425K | $26.67 | $11.3M |
| Feb 11, 2026 | Gold Daniel Allen | Director | Sell(S) | 425K | $26.67 | $11.3M |
| Feb 11, 2026 | Manchester Keith S | Director | Sell(S) | 425K | $26.67 | $11.3M |
| Feb 9, 2026 | Sukhatme Mayukh | President & CIO, Director | Sell(S) | 339K | $26.47 | $9.0M |
| Feb 9, 2026 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 652K | $12.68 | $8.3M |
| Feb 9, 2026 | Sukhatme Mayukh | President & CIO, Director | Other(J) | 312K | $26.47 | $8.3M |
| Feb 9, 2026 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 652K | — | $0 |
| Jan 20, 2026 | Epperly Melissa B, | Director | Tax withholding(F) | 54 | $22.98 | $1K |
| Jan 20, 2026 | Epperly Melissa B, | Director | Grant(A) | 815 | — | $0 |
| Jan 20, 2026 | Oren Ilan | Director | Grant(A) | 1K | — | $0 |
| Jan 20, 2026 | Oren Ilan | Director | Tax withholding(F) | 124 | $22.98 | $3K |
| Jan 20, 2026 | Momtazee James C | Director | Tax withholding(F) | 122 | $22.98 | $3K |
| Jan 20, 2026 | Momtazee James C | Director | Grant(A) | 609 | — | $0 |
| Jan 12, 2026 | Venker Eric | President & Immunovant CEO | Sell(S) | 200K | $21.92 | $4.4M |
| Jan 12, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | $3.85 | $770K |
| Jan 12, 2026 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 200K | — | $0 |
| Dec 31, 2025 | Sukhatme Mayukh | President & CIO, Director | Other(J) | 1.4M | $21.71 | $31.1M |
| Dec 31, 2025 | Sukhatme Mayukh | President & CIO, Director | Sell(S) | 1.0M | $21.71 | $22.1M |
| Dec 31, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 2.4M | $12.68 | $31.1M |
| Dec 31, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 2.4M | — | $0 |
| Dec 29, 2025 | Sukhatme Mayukh | President & CIO, Director | Sell(S) | 312K | $21.74 | $6.8M |
| Dec 29, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 748K | $12.68 | $9.5M |
| Dec 29, 2025 | Sukhatme Mayukh | President & CIO, Director | Other(J) | 436K | $21.74 | $9.5M |
| Dec 29, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 748K | — | $0 |
| Dec 24, 2025 | Venker Eric | President & Immunovant CEO | Sell(S) | 75K | $22.53 | $1.7M |
| Dec 24, 2025 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 118K | $3.85 | $454K |
| Dec 24, 2025 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 118K | — | $0 |
| Dec 24, 2025 | Torti Frank | President and Vant Chair | Other(J) | 65K | $22.47 | $1.5M |
| Dec 24, 2025 | Torti Frank | President and Vant Chair | Gift(G) | 110K | — | $0 |
| Dec 23, 2025 | Venker Eric | President & Immunovant CEO | Sell(S) | 200K | $22.45 | $4.5M |
| Dec 23, 2025 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 314K | $3.85 | $1.2M |
| Dec 23, 2025 | Venker Eric | President & Immunovant CEO | Option exercise(M) | 314K | — | $0 |
| Dec 23, 2025 | Pulik Richard | CFO | Sell(S) | 147K | $22.39 | $3.3M |
| Dec 23, 2025 | Pulik Richard | CFO | Sell(S) | 260K | $22.45 | $5.8M |
| Dec 23, 2025 | Pulik Richard | CFO | Option exercise(M) | 260K | $3.85 | $1.0M |
| Dec 23, 2025 | Pulik Richard | CFO | Option exercise(M) | 260K | — | $0 |
| Dec 23, 2025 | Torti Frank | President and Vant Chair | Grant(A) | 175K | $22.45 | $3.9M |
| Dec 20, 2025 | Pulik Richard | CFO | Tax withholding(F) | 2K | $22.41 | $48K |
| Dec 17, 2025 | Sukhatme Mayukh | President & CIO, Director | Other(J) | 33K | $23.09 | $755K |
| Dec 17, 2025 | Sukhatme Mayukh | President & CIO, Director | Sell(S) | 27K | $23.09 | $620K |
| Dec 17, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 60K | $12.68 | $755K |
| Dec 17, 2025 | Sukhatme Mayukh | President & CIO, Director | Option exercise(M) | 60K | — | $0 |
| Dec 17, 2025 | QVT Financial LP | Insider | Sell(S) | 433K | $23.05 | $10.0M |
| Dec 17, 2025 | QVT Financial LP | Insider | Sell(S) | 190K | $23.17 | $4.4M |
| Dec 17, 2025 | QVT Financial LP | Insider | Sell(S) | 155K | $23.02 | $3.6M |
| Dec 17, 2025 | Manchester Keith S | Director | Sell(S) | 190K | $23.17 | $4.4M |
| Dec 17, 2025 | Manchester Keith S | Director | Sell(S) | 433K | $23.05 | $10.0M |
| Dec 17, 2025 | Manchester Keith S | Director | Sell(S) | 155K | $23.02 | $3.6M |
| Dec 17, 2025 | Gold Daniel Allen | Director | Sell(S) | 190K | $23.17 | $4.4M |
| Dec 17, 2025 | Gold Daniel Allen | Director | Sell(S) | 155K | $23.02 | $3.6M |
| Dec 17, 2025 | Gold Daniel Allen | Director | Sell(S) | 433K | $23.05 | $10.0M |
| Dec 16, 2025 | QVT Financial LP | Insider | Sell(S) | 642K | $23.08 | $14.8M |
| Dec 16, 2025 | QVT Financial LP | Insider | Sell(S) | 275K | $22.93 | $6.3M |
| Dec 16, 2025 | Manchester Keith S | Director | Sell(S) | 275K | $22.93 | $6.3M |
| Dec 16, 2025 | Manchester Keith S | Director | Sell(S) | 642K | $23.08 | $14.8M |
| Dec 16, 2025 | Gold Daniel Allen | Director | Sell(S) | 642K | $23.08 | $14.8M |
| Dec 16, 2025 | Gold Daniel Allen | Director | Sell(S) | 275K | $22.93 | $6.3M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Sell(S) | 944K | $21.68 | $20.5M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Other(J) | 4K | $21.68 | $81K |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Option exercise(M) | 2.3M | $12.68 | $28.8M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Option exercise(M) | 234K | $4.06 | $950K |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Sell(S) | 230K | $21.68 | $5.0M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Option exercise(M) | 1.4M | $12.68 | $17.3M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Sell(S) | 566K | $21.68 | $12.3M |
| Dec 15, 2025 | Gline Matthew | CEO, Director | Other(J) | 798K | $21.68 | $17.3M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).